The stock of Ardent Health Partners Inc (ARDT) has seen a -11.75% decrease in the past week, with a -17.06% drop in the past month, and a -25.97% decrease in the past quarter. The volatility ratio for the week is 5.71%, and the volatility levels for the past 30 days are at 4.24% for ARDT. The simple moving average for the past 20 days is -13.72% for ARDT’s stock, with a -19.20% simple moving average for the past 200 days.
Is It Worth Investing in Ardent Health Partners Inc (NYSE: ARDT) Right Now?
Ardent Health Partners Inc (NYSE: ARDT) has a higher price-to-earnings ratio of 21.82x compared to its average ratio. Analysts have mixed views on the stock, with 6 analysts rating it as a “buy,” 2 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for ARDT is 22.88M, and currently, short sellers hold a 7.21% ratio of that float. The average trading volume of ARDT on January 15, 2025 was 249.04K shares.
ARDT) stock’s latest price update
The stock price of Ardent Health Partners Inc (NYSE: ARDT) has dropped by -12.46 compared to previous close of 16.05. Despite this, the company has seen a fall of -11.75% in its stock price over the last five trading days. businesswire.com reported 2025-01-03 that BRENTWOOD, Tenn.–(BUSINESS WIRE)–Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced it has acquired 18 urgent care clinics across New Mexico and Oklahoma from NextCare Urgent Care. “Expanding our urgent care footprint represents significant progress in our mission to create a consumer-focused ecosystem of care in each of the communities we serve,” said Ardent Health President and CEO Marty Bonick. “We’re helping.
Analysts’ Opinion of ARDT
Many brokerage firms have already submitted their reports for ARDT stocks, with JP Morgan repeating the rating for ARDT by listing it as a “Neutral.” The predicted price for ARDT in the upcoming period, according to JP Morgan is $20 based on the research report published on December 17, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see ARDT reach a price target of $19, previously predicting the price at $22. The rating they have provided for ARDT stocks is “Neutral” according to the report published on November 06th, 2024.
KeyBanc Capital Markets gave a rating of “Overweight” to ARDT, setting the target price at $24 in the report published on October 11th of the previous year.
ARDT Trading at -15.13% from the 50-Day Moving Average
After a stumble in the market that brought ARDT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.19% of loss for the given period.
Volatility was left at 4.24%, however, over the last 30 days, the volatility rate increased by 5.71%, as shares sank -15.87% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -23.93% lower at present.
During the last 5 trading sessions, ARDT fell by -11.75%, in comparison to the 20-day moving average, which settled at $16.28. In addition, Ardent Health Partners Inc saw -17.74% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ARDT starting from Webb Robert Thomas, who purchase 20,000 shares at the price of $16.98 back on Nov 08 ’24. After this action, Webb Robert Thomas now owns 40,275 shares of Ardent Health Partners Inc, valued at $339,600 using the latest closing price.
Stock Fundamentals for ARDT
Current profitability levels for the company are sitting at:
- 0.04 for the present operating margin
- 0.84 for the gross margin
The net margin for Ardent Health Partners Inc stands at 0.02. The total capital return value is set at 0.06.
Based on Ardent Health Partners Inc (ARDT), the company’s capital structure generated 0.46 points at debt to capital in total, while cash flow to debt ratio is standing at 0.22. The debt to equity ratio resting at 0.84. The interest coverage ratio of the stock is 3.99.
Currently, EBITDA for the company is 350.0 million with net debt to EBITDA at 1.49. When we switch over and look at the enterprise to sales, we see a ratio of 0.46. The receivables turnover for the company is 8.08for trailing twelve months and the total asset turnover is 1.19. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.91.
Conclusion
To put it simply, Ardent Health Partners Inc (ARDT) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
